Epperly Melissa B,
CIK 1807359 · Chief Financial Officer · last filed 2026-07-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.66M
Companies
5
Total Filings
57
Lifetime Open-Market Net
-$4.97M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | Director | 17,017 | $33.84 | $575.9K | -$1.81M | 18 | 2026-07-21 |
| NAUT | Director | — | $1.20 | — | $0 | 5 | 2026-06-22 |
| ZNTL | Chief Financial Officer | 451,449 | $4.62 | $2.09M | -$3.15M | 23 | 2024-02-12 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 1,280 | $2.75 | $3.5K | $0 | 2 | 2023-07-06 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 3 | 2023-06-13 |
Recent Filings · Page 3 of 6
57 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-05 | — | Disp (D) | — | $0 | |
| 2024-02-12 | ZNTL | Notice (144) | −2,573 | -$29.4K | EDGAR |
| 2024-02-12 | ZNTL | Sell (S) | −2,573 | -$29.4K | EDGAR |
| 2024-02-05 | ZNTL | Mixed | +66,331 | -$100.0K | EDGAR |
| 2024-02-02 | ZNTL | Notice (144) | −8,669 | -$100.0K | EDGAR |
| 2024-01-23 | ROIV | Grant (A) | +1,207 | $0 | EDGAR |
| 2023-10-18 | ROIV | Grant (A) | +1,226 | $0 | EDGAR |
| 2023-10-06 | ZNTL | Sell (S) | −5,482 | -$106.9K | EDGAR |
| 2023-10-04 | ZNTL | Notice (144) | −5,482 | -$106.9K | EDGAR |
| 2023-09-14 | ROIV | Grant (A) | +17,825 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.